Pieris Pharmaceuticals Inc (NASDAQ:PIRS)
| 1.97 Delayed Data As of Jun 24 |  +0.10 / +5.35%Today’s Change | 1.54 Today|||52-Week Range 6.15 | -47.88% Year-to-Date |
Latest PIRS News | Press Releases
No recent news for Pieris Pharmaceuticals Inc.
Today’s Trading
| Previous close | 1.87 |
| Today’s open | 1.89 |
| Day’s range | 1.89 - 1.97 |
| Volume | 8,100 |
| Average volume (3 months) | 413,056 |
| Market cap | $143.8M |
Data as of 4:01pm ET, 06/24/2022
Growth & Valuation
| Earnings growth (last year) | -3.69% |
| Earnings growth (this year) | +42.25% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +7.14% |
| P/E ratio | NM |
| Price/Sales | 7.77 |
| Price/Book | 2.77 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INMBINmune Bio Inc | -0.16 | -1.94% |
| RCELAVITA Medical Inc | +0.53 | +9.87% |
| JNCEJounce Therapeutics ... | -0.26 | -8.50% |
| DTILPrecision BioScience... | +0.01 | +0.68% |
Data as of 4:04pm ET, 06/24/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $31.4M |
| Annual profit (last year) | -$45.7M |
| Net profit margin | -145.58% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
